Home › Funds › IMC-Chicago, LLC › ABBV

IMC-Chicago, LLC position in ABBV

ABBVIE INC · Health Care

IMC-Chicago, LLC reported holding 869,700 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$227.5M, representing 0.38% of its reported portfolio and ranking #41 among its reported holdings. IMC-Chicago, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)869.70K sh
Reported value held$227.50M
Portfolio Weight0.38%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How IMC-Chicago, LLC's ABBV position evolved

IMC-Chicago, LLC first disclosed a stake in ABBV in Q3 2023 at 12,932 shares (US$1.9M). The position peaked in Q3 2026 at 869,700 shares, worth US$227.5M. Across 13 filings, IMC-Chicago, LLC increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 869,700 shares valued at US$227.5M — an increase of 298,200 shares quarter over quarter.. Notable position changes include a 1775% increase in Q4 2023 (shares rose 19% over the following quarter), a 1174% increase in Q3 2025 (shares were roughly flat over the following quarter), a 311% increase in Q1 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.93K $1.93M New
Q4 2023 242.50K $37.58M Add
Q1 2024 220.80K $40.21M Reduce
Q2 2024 306.90K $52.64M Add
Q3 2024 39.38K $7.78M Reduce
Q4 2024 59.65K $10.60M Add
Q1 2025 31.07K $6.51M Reduce
Q2 2025 38.95K $7.23M Add
Q3 2025 496.10K $114.87M Add
Q4 2025 91.29K $20.86M Reduce
Q1 2026 375.60K $81.69M Add
Q2 2026 571.50K $143.81M Add
Q3 2026 869.70K $227.50M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has IMC-Chicago, LLC held ABBV?

IMC-Chicago, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is IMC-Chicago, LLC's current position in ABBV?

As of Q3 2026, IMC-Chicago, LLC holds 869.70K shares of ABBV (ABBVIE INC), valued at $227.50M, representing 0.38% of its reported portfolio and ranking #41.

Has IMC-Chicago, LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), IMC-Chicago, LLC increased its position in ABBV. The position peaked in Q3 2026 at 869.70K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.